MER Indicator |
MER description |
Target Fiscal Year |
Target |
GEND_GBV |
Number of people receiving post-GBV care |
2015 |
20 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
10 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
50 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
6,000 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
6,060 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
10 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
6,050 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
6,060 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
105 |
KP_PREV |
By key population type: Men who have sex with men/Transgender (MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
15,212 |
KP_PREV |
By key population type: MSM/TG who are male sex workers (subset MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2015 |
250 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2015 |
15,567 |
PP_PREV |
Age/sex: 10-14 Male |
2015 |
95 |
PP_PREV |
Age/sex: 15-19 Female |
2015 |
1,338 |
PP_PREV |
Age/sex: 15-19 Male |
2015 |
5,915 |
PP_PREV |
Age/sex: 25-49 Male |
2015 |
8,868 |
PP_PREV |
Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period |
2015 |
16,216 |
PP_PREV |
Sum of Age/Sex disaggregates |
2015 |
16,216 |
TX_CURR |
Age/Sex: 15+ Female |
2015 |
50 |
TX_CURR |
Age/Sex: 15+ Male |
2015 |
1,350 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
50 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
1,350 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
1,400 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
1,400 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
1,400 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
5 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
465 |
TX_NEW |
By Age/Sex: 15-19 Female |
2015 |
5 |
TX_NEW |
By Age/Sex: 50+ Male |
2015 |
465 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
470 |
TX_NEW |
Sum of Age/Sex disaggregates |
2015 |
470 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
470 |
TX_RET |
Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2015 |
150 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
150 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
173 |
TX_RET_den |
Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2015 |
173 |